Spain · Delayed Price · Currency is EUR Making Science Group Statistics
Total Valuation
BME:MAKS has a market cap or net worth of EUR 67.84 million. The enterprise value is 81.39 million.
| Market Cap | 67.84M |
| Enterprise Value | 81.39M |
Important Dates
The last earnings date was Friday, April 24, 2026.
| Earnings Date | Apr 24, 2026 |
| Ex-Dividend Date | Apr 28, 2026 |
Share Statistics
BME:MAKS has 9.04 million shares outstanding. The number of shares has increased by 1.27% in one year.
| Current Share Class | 9.04M |
| Shares Outstanding | 9.04M |
| Shares Change (YoY) | +1.27% |
| Shares Change (QoQ) | -2.33% |
| Owned by Insiders (%) | 6.21% |
| Owned by Institutions (%) | 3.54% |
| Float | 3.72M |
Valuation Ratios
The trailing PE ratio is 2.73.
| PE Ratio | 2.73 |
| Forward PE | n/a |
| PS Ratio | 0.19 |
| PB Ratio | 1.53 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 1.77 |
| P/OCF Ratio | 1.76 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.60, with an EV/FCF ratio of 2.12.
| EV / Earnings | 3.28 |
| EV / Sales | 0.23 |
| EV / EBITDA | 26.60 |
| EV / EBIT | n/a |
| EV / FCF | 2.12 |
Financial Position
The company has a current ratio of 0.84, with a Debt / Equity ratio of 0.83.
| Current Ratio | 0.84 |
| Quick Ratio | 0.77 |
| Debt / Equity | 0.83 |
| Debt / EBITDA | 12.13 |
| Debt / FCF | 0.97 |
| Interest Coverage | 0.04 |
Financial Efficiency
Return on equity (ROE) is -20.20% and return on invested capital (ROIC) is 0.36%.
| Return on Equity (ROE) | -20.20% |
| Return on Assets (ROA) | 0.07% |
| Return on Invested Capital (ROIC) | 0.36% |
| Return on Capital Employed (ROCE) | 0.35% |
| Weighted Average Cost of Capital (WACC) | 9.14% |
| Revenue Per Employee | 419,629 |
| Profits Per Employee | 29,919 |
| Employee Count | 830 |
| Asset Turnover | 1.96 |
| Inventory Turnover | 106.44 |
Taxes
In the past 12 months, BME:MAKS has paid 905,857 in taxes.
| Income Tax | 905,857 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.35% in the last 52 weeks. The beta is 0.89, so BME:MAKS's price volatility has been lower than the market average.
| Beta (5Y) | 0.89 |
| 52-Week Price Change | -19.35% |
| 50-Day Moving Average | 7.84 |
| 200-Day Moving Average | 8.37 |
| Relative Strength Index (RSI) | 36.43 |
| Average Volume (20 Days) | 3,293 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:MAKS had revenue of EUR 348.29 million and earned 24.83 million in profits. Earnings per share was 2.83.
| Revenue | 348.29M |
| Gross Profit | 22.17M |
| Operating Income | 186,146 |
| Pretax Income | -6.68M |
| Net Income | 24.83M |
| EBITDA | 905,329 |
| EBIT | 186,146 |
| Earnings Per Share (EPS) | 2.83 |
Balance Sheet
The company has 29.70 million in cash and 37.10 million in debt, with a net cash position of -7.40 million or -0.82 per share.
| Cash & Cash Equivalents | 29.70M |
| Total Debt | 37.10M |
| Net Cash | -7.40M |
| Net Cash Per Share | -0.82 |
| Equity (Book Value) | 44.48M |
| Book Value Per Share | 4.24 |
| Working Capital | -20.41M |
Cash Flow
In the last 12 months, operating cash flow was 38.55 million and capital expenditures -172,231, giving a free cash flow of 38.38 million.
| Operating Cash Flow | 38.55M |
| Capital Expenditures | -172,231 |
| Depreciation & Amortization | 719,183 |
| Net Borrowing | -17.63M |
| Free Cash Flow | 38.38M |
| FCF Per Share | 4.24 |
Margins
Gross margin is 6.36%, with operating and profit margins of 0.05% and 7.13%.
| Gross Margin | 6.36% |
| Operating Margin | 0.05% |
| Pretax Margin | -1.92% |
| Profit Margin | 7.13% |
| EBITDA Margin | 0.26% |
| EBIT Margin | 0.05% |
| FCF Margin | 11.02% |
Dividends & Yields
This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 2.96%.
| Dividend Per Share | 0.22 |
| Dividend Yield | 2.96% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.27% |
| Shareholder Yield | 1.70% |
| Earnings Yield | 36.61% |
| FCF Yield | 56.58% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BME:MAKS has an Altman Z-Score of 2.14 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.14 |
| Piotroski F-Score | 6 |